Table 2.
Descriptive clinical data of individuals with newly diagnosed type 2 diabetes in low-income community clinics N=489).
| Insulin Initiation | OAA Initiation | p | |
|---|---|---|---|
| A1c (%) | |||
| Month 0 | 11.25 (+2.1) | 9.40 (+2.1) | <0.001 |
| Month 6 | 7.21 (+1.7) | 6.93 (+1.4) | 0.192 |
| Month 12 | 7.73 (+2.1) | 7.22 (+1.7) | 0.064 |
| Systolic Blood Pressure (mmHg) | |||
| Month 0 | 129.1 (+18.4) | 130.5 (+18.1) | 0.428 |
| Month 12 | 129.4 (+18.0) | 120.2 (+19.8) | 0.762 |
| Diastolic Blood Pressure (mmHg) | |||
| Month 0 | 78.9 (+11.7) | 80.5 (+17.9) | 0.493 |
| Month 12 | 77.8 (+11.4) | 77.4 (+11.9) | 0.936 |
| Cholesterol (mg/dL) | |||
| Month 0 | |||
| Total Cholesterol | 192.7 (+53.1) | 204.9 (+46.8) | 0.037 |
| High-density lipoprotein | 37.5 (+46.6) | 33.0 (+91.2) | 0.673 |
| Low-density lipoprotein | 110.0 (+60.7) | 125.0 (+99.2) | 0.208 |
| Triglycerides | 225.7 (+223.2) | 234.3 (+262.5) | 0.786 |
| Month 12 | |||
| Total Cholesterol | 180.0 (+46.2) | 184.4 (+40.8) | 0.484 |
| High-density lipoprotein | 39.5 (+18.5) | 40.8 (+18.5) | 0.642 |
| Low-density lipoprotein | 104.0 (+36.5) | 106.0 (+32.6) | 0.662 |
| Triglycerides | 182.5 (+172.5) | 188.5 (+143.3) | 0.775 |
| BMI (kg/m2) | |||
| Month 0 | 31.5 (+7.2) | 33.3 (+7.6) | 0.035 |
| Month 12 | 33.1 (+ 7.1) | 33.2 (+7.2) | 0.326 |
| EDC visits (0 to 12 months) (SD) | 0.169 (+0.43) | 0.0025 (±0.05) | 0.005 |
A
OAs: Oral Hypoglycemic Agents